Drupal.behaviors.print = function(context) {window.print();window.close();}>
Dx Focus: Roche CT/NG Test Gets FDA OK; Pinpoint Genomics and BioReference Labs Launch Cancer Assays
February 02, 2012
Dx Focus: Roche CT/NG Test Gets FDA OK; Pinpoint Genomics and BioReference Labs Launch Cancer Assays
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Dx Focus: Clinical and Regulatory PCR and Nucleic Acid Testing News
May 12, 2011 / PCR Insider
Cepheid Highlights Strong Uptake of Xpert CT/NG as Q1 Revenues Rise 19 Percent
April 25, 2013 / PCR Insider
On Heels of FDA Approval, Cepheid's Xpert CT/NG Test Performs Well in Multi-Center Clinical Study
March 14, 2013 / PCR Insider
NetBio Says Multiple-Biomarker Chlamydia Assay Outperforms Established Commercial Test
January 3, 2013 / PCR Insider
PerkinElmer Buys Shanghai Haoyuan for Near-Term Blood Screening Play, Longer Term MDx Initiative
November 15, 2012 / PCR Insider